TLR3-mediated Astrocyte Responses in High and Normal Glucose Adaptation Differently Regulated by Metformin

Overview

Journal Cell Biochem Biophys

Specialties Biochemistry
Biophysics
Cell Biology

Date 2024 Jun 25

PMID 38918312

Authors

Vladislav O Gorbatenko

Sergey V Goriainov

Valentina A Babenko

Egor Y Plotnikov

Dmitry V Chistyakov

Marina G Sergeeva

Affiliations

Soon will be listed here.

Abstract

Toll-like receptors 3 (TLR3) are innate immune receptors expressed on a wide range of cell types, including glial cells. Inflammatory responses altered by hyperglycemia highlight the need to explore the molecular underpinnings of these changes in cellular models. Therefore, here we estimated TLR3-mediated response of astrocytes cultured at normal (NG, 5 mM) and high (HG, 22.5 mM) glucose concentrations for 48 h before stimulation with polyinosinic:polycytidylic acid Poly(I:C) (PIC) for 6 h. Seahorse Extracellular Flux Analyzer (Seahorse XFp) was used to estimate the extracellular acidification rate (ECAR) and oxygen consumption rate (OCR). Although adaptation to HG affected ECAR and OCR, the stimulation of cells with PIC had no effect on ECAR. PIC reduced maximal OCR, but this effect disappeared upon adaptation to HG. PIC-stimulated release of cytokines IL-1β, IL-10 was reduced, and that of IL-6 and iNOS was increased in the HG model. Adaptation to HG reduced PIC-stimulated synthesis of COX-derived oxylipins measured by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Adaptation to HG did not alter PIC-stimulated p38 activity, ERK mitogen-activated protein kinase, STAT3 and ROS production. Metformin exhibited anti-inflammatory activity, reducing PIC-stimulated synthesis of cytokines and oxylipins. Cell adaptation to high glucose concentration altered the sensitivity of astrocytes to TLR3 receptor activation, and the hypoglycemic drug metformin may exert anti-inflammatory effects under these conditions.

References

Ristow M . Neurodegenerative disorders associated with diabetes mellitus. J Mol Med (Berl). 2004; 82(8):510-29. DOI: 10.1007/s00109-004-0552-1. View

Jafar N, Edriss H, Nugent K . The Effect of Short-Term Hyperglycemia on the Innate Immune System. Am J Med Sci. 2016; 351(2):201-11. DOI: 10.1016/j.amjms.2015.11.011. View

Belanger M, Allaman I, Magistretti P . Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 2011; 14(6):724-38. DOI: 10.1016/j.cmet.2011.08.016. View

Selvarajah D, Tesfaye S . Central nervous system involvement in diabetes mellitus. Curr Diab Rep. 2006; 6(6):431-8. DOI: 10.1007/s11892-006-0075-y. View

Farina C, Aloisi F, Meinl E . Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007; 28(3):138-45. DOI: 10.1016/j.it.2007.01.005. View

Chistyakov D, Astakhova A, Sergeeva M . Resolution of inflammation and mood disorders. Exp Mol Pathol. 2018; 105(2):190-201. DOI: 10.1016/j.yexmp.2018.08.002. View

Cunningham C, Dunne A, Lopez-Rodriguez A . Astrocytes: Heterogeneous and Dynamic Phenotypes in Neurodegeneration and Innate Immunity. Neuroscientist. 2018; 25(5):455-474. PMC: 6525076. DOI: 10.1177/1073858418809941. View

Escartin C, Galea E, Lakatos A, OCallaghan J, Petzold G, Serrano-Pozo A . Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021; 24(3):312-325. PMC: 8007081. DOI: 10.1038/s41593-020-00783-4. View

Li L, Acioglu C, Heary R, Elkabes S . Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases. Brain Behav Immun. 2020; 91:740-755. PMC: 7543714. DOI: 10.1016/j.bbi.2020.10.007. View

10.

Sofroniew M . Astrocyte barriers to neurotoxic inflammation. Nat Rev Neurosci. 2015; 16(5):249-63. PMC: 5253239. DOI: 10.1038/nrn3898. View

11.

Kawai T, Akira S . Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011; 34(5):637-50. DOI: 10.1016/j.immuni.2011.05.006. View

12.

Alexopoulou L, Holt A, Medzhitov R, Flavell R . Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001; 413(6857):732-8. DOI: 10.1038/35099560. View

13.

Swanson 2nd P, McGavern D . Viral diseases of the central nervous system. Curr Opin Virol. 2015; 11:44-54. PMC: 4456224. DOI: 10.1016/j.coviro.2014.12.009. View

14.

Scumpia P, Kelly K, Reeves W, Stevens B . Double-stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3-expressing astrocytes. Glia. 2005; 52(2):153-62. DOI: 10.1002/glia.20234. View

15.

Chistyakov D, Azbukina N, Lopachev A, Kulichenkova K, Astakhova A, Sergeeva M . Rosiglitazone as a Modulator of TLR4 and TLR3 Signaling Pathways in Rat Primary Neurons and Astrocytes. Int J Mol Sci. 2018; 19(1). PMC: 5796062. DOI: 10.3390/ijms19010113. View

16.

Chistyakov D, Azbukina N, Astakhova A, Polozhintsev A, Sergeeva M, Reiser G . Toll-like receptors control p38 and JNK MAPK signaling pathways in rat astrocytes differently, when cultured in normal or high glucose concentrations. Neurochem Int. 2019; 131:104513. DOI: 10.1016/j.neuint.2019.104513. View

17.

Jing Y, Wu F, Li D, Yang L, Li Q, Li R . Metformin improves obesity-associated inflammation by altering macrophages polarization. Mol Cell Endocrinol. 2017; 461:256-264. DOI: 10.1016/j.mce.2017.09.025. View

18.

Qi T, Chen Y, Li H, Pei Y, Woo S, Guo X . A role for /iPFK2 in metformin suppression of adipocyte inflammatory responses. J Mol Endocrinol. 2017; 59(1):49-59. PMC: 5512603. DOI: 10.1530/JME-17-0066. View

19.

Markowicz-Piasecka M, Sikora J, Szydlowska A, Skupien A, Mikiciuk-Olasik E, Huttunen K . Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla. Pharm Res. 2017; 34(12):2614-2627. PMC: 5736777. DOI: 10.1007/s11095-017-2199-y. View

20.

Li W, Chaudhari K, Shetty R, Winters A, Gao X, Hu Z . Metformin Alters Locomotor and Cognitive Function and Brain Metabolism in Normoglycemic Mice. Aging Dis. 2019; 10(5):949-963. PMC: 6764722. DOI: 10.14336/AD.2019.0120. View